Lenalidomide plus dexamethasone versus thalidomide plus dexamethasone in newly diagnosed multiple myeloma: a comparative analysis of 411 patients

The objective of this case-control study was to compare the efficacy and toxicity of lenalidomide plus dexamethasone (len/dex) versus thalidomide plus dexamethasone (thal/dex) as initial therapy for newly diagnosed myeloma. We retrospectively studied 411 newly diagnosed patients treated with len/dex...

Полное описание

Сохранить в:
Библиографические подробности
Главные авторы: Gay, Francesca, Hayman, Suzanne R., Lacy, Martha Q., Buadi, Francis, Gertz, Morie A., Kumar, Shaji, Dispenzieri, Angela, Mikhael, Joseph R., Bergsagel, P. Leif, Dingli, David, Reeder, Craig B., Lust, John A., Russell, Stephen J., Roy, Vivek, Zeldenrust, Steven R., Witzig, Thomas E., Fonseca, Rafael, Kyle, Robert A., Greipp, Philip R., Stewart, A. Keith, Rajkumar, S. Vincent
Формат: Artigo
Язык:Inglês
Опубликовано: American Society of Hematology 2010
Предметы:
Clinical Trials and Observations
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC2826759/
https://ncbi.nlm.nih.gov/pubmed/20008302
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2009-08-239046
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы